GlassScriptPhysician profile
Birenkumar Rajandrakumar Patel
NPI 1679900062
$1,078.60
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $231.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $161.75 | 2019-2020 | |
| Ge Healthcare | $129.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $108.72 | 2019-2020 | |
| Allergan, INC. | $68.55 | 2019-2020 | |
| Corcept Therapeutics | $62.28 | 2019 | |
| Lilly USA, LLC | $55.98 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $50.25 | 2019-2020 | |
| Genzyme Corporation | $46.08 | 2019 | |
| Acadia Pharmaceuticals INC | $45.82 | 2019 | |
| Supernus Pharmaceuticals, INC. | $42.78 | 2019 | |
| Shire North American Group INC | $41.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.60 | 2019 | |
| Radius Health, INC. | $31.54 | 2019 | |
| Biogen, INC. | $31.08 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $29.72 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.90 | 2020 | |
| Amneal Pharmaceuticals LLC | $20.31 | 2020 | |
| Novo Nordisk INC | $19.16 | 2019 | |
| Tanabe Pharma America, INC. | $17.95 | 2020 | |
| Csl Behring | $17.88 | 2020 | |
| Pfizer INC. | $17.18 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.74 | 2019 | |
| Grifols USA, LLC | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Birenkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.